Business
FDA Launches New Initiative for Drug Manufacturing
Eli Lilly and Regeneron are among the first companies selected by the FDA for its PreCheck Pilot Program to speed review of new manufacturing facilities. Chip stocks rebound, and Goldman Sachs secures several M&A deals.
Coverage timeline — 2 articles
CNBC
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
2026-06-29 18:36 UTC
CNBC
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
2026-06-29 18:50 UTC